Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Promising HIV vaccine to be tested with gay men and trans people

A new phase III HIV vaccine trial will soon be underway for men who have sex with men and transgender people. The study, called Mosaico, will evaluate

Published
22 July 2019
By
Liz Highleyman
PrEP services could enhance STI control, says World Health Organization

The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better

Published
22 July 2019
By
Roger Pebody
Universal Test and Treat Won't Stop HIV Epidemic

Universal test-and-treat strategies resulted in "modest to no reductions" in new HIV transmissions in three large population-based studies, writes Salim Abdool-Karim, MD, ChB, PhD, of the Centre for the AIDS Programme of Research in South Africa, in a commentary published online today in the New England Journal of Medicine.

Published
20 July 2019
From
Medscape (requires free registration)
The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa. But, as the Bhekisisa Centre for Health Journalism reports, popping a pill every day to stay HIV-negative may not be for everyone. For young women, hassle-free alternatives are on the horizon.

Published
20 July 2019
From
Mail & Guardian
China to launch clinical trial of long-lasting HIV vaccine: paper

Chinese scientists will begin the second-phase clinical trial of an HIV vaccine on 160 volunteers, Friday's China Daily reported. The candidate vaccine, DNA-rTV, relies on replication of the DNA of HIV to stimulate effective immunization.

Published
20 July 2019
From
Xinhua
Intensive Anti-H.I.V. Efforts Meet With Mixed Success in Africa

Scientists tested a costly approach to curbing the AIDS epidemic: Test everyone in the community, and treat anyone who is infected.

Published
20 July 2019
From
New York Times
How can researchers reduce risks to sexual partners in studies involving treatment interruptions?

As studies working towards a functional cure or HIV eradication are creating risks not only for the HIV-positive people who take part, but also their sexual partners,

Published
20 July 2019
By
Roger Pebody
What’s the relationship between PrEP, condom use and STIs?

HIV experts and professionals agree that pre-exposure prophylaxis (PrEP) is a valuable addition to HIV prevention, but have varied views of the relationship between PrEP, reduced condom use

Published
17 July 2019
By
Roger Pebody
Can free schools in South Africa reduce HIV risk?

In our study, we wanted to examine why adolescent girls are engaging in risky sexual behaviour. Is this behaviour driven by childhood adversity, such as poverty, coming from a family where someone is ill with HIV/AIDS, or exposure to violence and experiencing psychological distress? We also wanted to find out if a government policy such as free schooling has the potential to mitigate some, or all, of these drivers.

Published
17 July 2019
From
The Conversation
‘A national crisis’: Drug-related deaths in Scotland at highest ever level

Almost 1,200 people in Scotland suffered a drug-related death last year, the highest number ever recorded, official statisitcs have revealed.

Published
17 July 2019
From
The Scotsman
← First12345...539Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.